213 related articles for article (PubMed ID: 24823996)
1. [Importance of PET for surgery of gastrointestinal stromal tumors].
Ronellenfitsch U; Wängler B; Niedermoser S; Dimitrakopoulou-Strauss A; Hohenberger P
Chirurg; 2014 Jun; 85(6):493-9. PubMed ID: 24823996
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
[TBL] [Abstract][Full Text] [Related]
3. Postoperative FDG-PET/CT staging in GIST: is there a benefit following R0 resection?
Hahn S; Bauer S; Heusner TA; Ebeling P; Hamami ME; Stahl A; Forsting M; Bockisch A; Antoch G
Eur J Radiol; 2011 Dec; 80(3):670-4. PubMed ID: 20970938
[TBL] [Abstract][Full Text] [Related]
4. F-18 FDG PET, CT, and MRI for detecting the malignant potential in patients with gastrointestinal stromal tumors: A protocol for a network meta-analysis of diagnostic test accuracy.
Wei K; Pan B; Yang H; Lu C; Ge L; Cao N
Medicine (Baltimore); 2018 Apr; 97(16):e0389. PubMed ID: 29668594
[TBL] [Abstract][Full Text] [Related]
5. Patterns of extension of gastrointestinal stromal tumors (GIST) treated with imatinib (Gleevec®) by 18F-FDG PET/CT.
Valls-Ferrusola E; García-Garzón JR; Ponce-López A; Soler-Peter M; Fuertes-Cabero S; Moragas-Solanes M; Riera-Gil E; Carrió-Gasset I; Lomeña-Caballero F
Rev Esp Enferm Dig; 2012 Jul; 104(7):360-6. PubMed ID: 22849497
[TBL] [Abstract][Full Text] [Related]
6. [Imaging procedures for gastrointestinal stromal tumors].
Antoch G; Herrmann K; Heusner TA; Buck AK
Radiologe; 2009 Dec; 49(12):1109-16. PubMed ID: 19787329
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of preoperative 18FDG positron-emission tomography and computed tomography for predicting the malignant potential of gastrointestinal stromal tumors.
Tokumoto N; Tanabe K; Misumi T; Fujikuni N; Suzuki T; Ohdan H
Dig Surg; 2014; 31(2):79-86. PubMed ID: 24776690
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of preoperative
Miyake KK; Nakamoto Y; Mikami Y; Tanaka S; Higashi T; Tadamura E; Saga T; Minami S; Togashi K
Eur Radiol; 2016 Dec; 26(12):4664-4674. PubMed ID: 26852217
[TBL] [Abstract][Full Text] [Related]
9. The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate.
Goerres GW; Stupp R; Barghouth G; Hany TF; Pestalozzi B; Dizendorf E; Schnyder P; Luthi F; von Schulthess GK; Leyvraz S
Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):153-62. PubMed ID: 15690223
[TBL] [Abstract][Full Text] [Related]
10. Correlation of measurements from diffusion weighted MR imaging and FDG PET/CT in GIST patients: ADC versus SUV.
Wong CS; Gong N; Chu YC; Anthony MP; Chan Q; Lee HF; Chu KM; Khong PL
Eur J Radiol; 2012 Sep; 81(9):2122-6. PubMed ID: 21955604
[TBL] [Abstract][Full Text] [Related]
11. Role of 18F-FDG PET/CT in restaging and follow-up of patients with GIST.
Albano D; Mattia B; Giubbini R; Bertagna F
Abdom Radiol (NY); 2020 Mar; 45(3):644-651. PubMed ID: 31646354
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic Features and Molecular Characteristics of Glucose Metabolism Contributing to ¹⁸F-fluorodeoxyglucose Uptake in Gastrointestinal Stromal Tumors.
Cho MH; Park CK; Park M; Kim WK; Cho A; Kim H
PLoS One; 2015; 10(10):e0141413. PubMed ID: 26509967
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study.
Goldstein D; Tan BS; Rossleigh M; Haindl W; Walker B; Dixon J
Oncology; 2005; 69(4):326-32. PubMed ID: 16293972
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal stromal tumors: diagnosis and treatment.
Acín-Gándara D; Pereira-Pérez F; Castaño-Pascual A; Durán-Poveda M; Antequera-Pérez A; Miliani-Molina C
Cir Cir; 2012; 80(1):44-51. PubMed ID: 22472152
[TBL] [Abstract][Full Text] [Related]
15. ¹⁸F-FDG PET/CT and contrast enhanced CT in differential diagnosis between leiomyoma and gastrointestinal stromal tumor.
Hirose Y; Kaida H; Kawahara A; Kurata S; Ishibashi M; Abe T
Hell J Nucl Med; 2015; 18(3):257-60. PubMed ID: 26574696
[TBL] [Abstract][Full Text] [Related]
16. Role of F-18-FDG-PET/CT in restaging of patients affected by gastrointestinal stromal tumours (GIST).
Bertagna F; Bosio G; Orlando E; Biasiotto G; Giubbini R
Nucl Med Rev Cent East Eur; 2010; 13(2):76-80. PubMed ID: 21598231
[TBL] [Abstract][Full Text] [Related]
17. The value of (18) F-fluorodeoxyglucose positron emission tomography for prediction of treatment response in gastrointestinal stromal tumors: a systematic review and meta-analysis.
Hassanzadeh-Rad A; Yousefifard M; Katal S; Asady H; Fard-Esfahani A; Moghadas Jafari A; Hosseini M
J Gastroenterol Hepatol; 2016 May; 31(5):929-35. PubMed ID: 26642423
[TBL] [Abstract][Full Text] [Related]
18. Multimodal functional imaging for early response assessment in patients with gastrointestinal stromal tumor treated with tyrosine kinase inhibitors.
Revheim ME; Hole KH; Mo T; Bruland ØS; Reitan E; Julsrud L; Seierstad T
Acta Radiol; 2022 Aug; 63(8):995-1004. PubMed ID: 34171968
[TBL] [Abstract][Full Text] [Related]
19. Assessment of early response to imatinib 800 mg after 400 mg progression by ¹⁸F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors.
Chacón M; Eleta M; Espindola AR; Roca E; Méndez G; Rojo S; Pupareli C
Future Oncol; 2015; 11(6):953-64. PubMed ID: 25760976
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal Stromal Tumors and the General Surgeon.
Caturegli I; Raut CP
Surg Clin North Am; 2022 Aug; 102(4):625-636. PubMed ID: 35952692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
